Blog
Number of PAs in US Increases 28% in Four Years
The number of physician assistants in the US grew by 28% from 2018 to 2022, and continued growth is predicted in coming years. The PA profession remains highly representative of women, with the gender distribution little changed in the past four years. Women account...
DEF Announces Travel Stipend for East Coast Biologic & Small Molecule Free CME Bootcamp
With planning well underway for next month's East Coast Biologic & Small Molecule Free CME Bootcamp, the Dermatology Education Foundation (DEF) has announced the availability of a travel stipend for all eligible health care providers who attend both days of the...
Skin Tests May Predict Food Allergies, Eczema
By Joe Gorelick, MSN, FNP-C This is very exciting information that may allow us to make early interventions that may modify to course of diseases. Analysis of tape strip samples from two-month babies predicted the likelihood of developing food allergies by age two,...
Second-Generation Melanoma Vaccine Shows Long-Term Benefits
By Joe Gorelick, MSN, FNP-C What’s new in the treatment of advanced melanoma? A second-generation melanoma vaccine appears to provide greater benefit than a first-generation vaccine, according to data from UVA Cancer Center, where the new vaccine was developed. The...
As Many as 7 in 10 Patients Report Significant Mental Health Impact from Eczema
As many as seven in 10 people with eczema report that the disease has had a negative impact on their mental health in the past year. About two-thirds of adults with eczema had anxiety scores that were "borderline abnormal" or "abnormal," and 46% had "borderline...
Tips for Nails on the Dermalorian™ Podcast
While some cases of nail disease can be fairly easy to diagnose, others can present a challenge. Atypical presentations and concomitant diseases are just a few of the potential impediments to accurate diagnosis and treatment. In this episode of the Dermalorian™...
FDA Accepts NDA for Journey’s Rosacea Candidate
The FDA has accepted the New Drug Application (NDA) from Journey Medical Corp. for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40mg) for the treatment of inflammatory lesions and erythema of rosacea in adults. The FDA has set a Prescription Drug User...
DERM2024 Call for Posters
We are now accepting e-poster submissions for DERM2024! Poster submissions are being accepted for digital display during the Clinically Relevant and Practical Case-Based Dermatology NP and PA CME Education Experience™. Posters may be submitted for inclusion in daily...
Sulfites are Allergen of the Year for 2024
By Joe Gorelick, MSN, FNP-C How many patients do you see with contact dermatitis? Negative patch testing results can be so frustrating and perhaps this year’s Allergen of the Year—sulfites--could be the culprit. Sulfites, commonly used preservatives in consumer...
$3.2 Million NIH Grant Funds Comprehensive Melanoma Initiative
A $3.2 million grant from the NIH will support the creation of Melanoma Resistance Evolution Atlas (MREA). Ultimately, researchers hope to develop novel approaches to prevention and treatment of resistant melanomas. Led by Dr. Roger Lo, professor of medicine and...